Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Michael Conn

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Methods in Enzymology|January 22, 2013
PrefaceP Michael Conn
Methods (San Diego, Calif.)|September 10, 2002
Measurement of changes in fluorescence resonance energy transfer between gonadotropin-releasing hormone receptors in response to agonistsAnda Cornea, P Michael Conn
Physiological Reviews|February 15, 2018
Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational DiseasesYa-Xiong Tao, P Michael Conn
Molecular and Cellular Endocrinology|December 9, 2008
Trafficking and quality control of the gonadotropin releasing hormone receptor in health and diseaseP Michael Conn, Jo Ann Janovick
Trends in Pharmacological Sciences|March 25, 2009
Drug development and the cellular quality control systemP Michael Conn, Jo Ann Janovick
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|November 15, 2011
Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptorsAlfredo Ulloa-Aguirre, P Michael Conn
Advances in Pharmacology (San Diego, Calif.)|September 13, 2011
Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptorsP Michael Conn, Alfredo Ulloa-Aguirre
Current Drug Targets|March 9, 2016
Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive MoleculesAlfredo Ulloa-Aguirre, P Michael Conn
Frontiers in Endocrinology|June 3, 2011
Pharmacoperone identification for therapeutic rescue of misfolded mutant proteinsP Michael Conn, Jo Ann Janovick
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Targeting of G protein-coupled receptors to the plasma membrane in health and diseaseAlfredo Ulloa-Aguirre, P Michael Conn
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Methods in Enzymology|January 22, 2013
PrefaceP Michael Conn
Methods (San Diego, Calif.)|September 10, 2002
Measurement of changes in fluorescence resonance energy transfer between gonadotropin-releasing hormone receptors in response to agonistsAnda Cornea, P Michael Conn
Physiological Reviews|February 15, 2018
Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational DiseasesYa-Xiong Tao, P Michael Conn
Molecular and Cellular Endocrinology|December 9, 2008
Trafficking and quality control of the gonadotropin releasing hormone receptor in health and diseaseP Michael Conn, Jo Ann Janovick
Trends in Pharmacological Sciences|March 25, 2009
Drug development and the cellular quality control systemP Michael Conn, Jo Ann Janovick
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|November 15, 2011
Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptorsAlfredo Ulloa-Aguirre, P Michael Conn
Advances in Pharmacology (San Diego, Calif.)|September 13, 2011
Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptorsP Michael Conn, Alfredo Ulloa-Aguirre
Current Drug Targets|March 9, 2016
Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive MoleculesAlfredo Ulloa-Aguirre, P Michael Conn
Frontiers in Endocrinology|June 3, 2011
Pharmacoperone identification for therapeutic rescue of misfolded mutant proteinsP Michael Conn, Jo Ann Janovick
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Targeting of G protein-coupled receptors to the plasma membrane in health and diseaseAlfredo Ulloa-Aguirre, P Michael Conn
Pageof 11